Long overdue: including adults with brain disorders in precision health initiatives
- PMID: 32544666
- PMCID: PMC7736248
- DOI: 10.1016/j.gde.2020.05.001
Long overdue: including adults with brain disorders in precision health initiatives
Abstract
Developmental brain disorders (DBD), including autism spectrum disorder, intellectual disability, and schizophrenia, are clinically defined and etiologically heterogeneous conditions with a wide range of outcomes. Rare pathogenic copy number and single nucleotide genomic variants are among the most common known etiologies, with diagnostic yields approaching for some DBD cohorts. Incorporating genetic testing into the care of adult patients with DBD, paired with targeted genetic counseling and family cascade testing, may increase self-advocacy and decrease stigma. In the long-term, breakthroughs in the understanding of DBD pathophysiology will hinge on the identification, engagement, and study of individuals with rare genetic DBD etiologies, consistent with successful precision medicine approaches to the treatment of cancer and cardiovascular disease.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
References
-
- Ismail FY, Shapiro BK: What are neurodevelopmental disorders? Curr Opin Neurol, 2019, 32:611–616. - PubMed
-
- Bergen SE, Ploner A, Howrigan D, CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium, O’Donovan MC, Smoller JW, Sullivan PF, Sebat J, Neale B, Kendler KS. Joint contributions of rare copy number variants and common SNPs to risk for schizophrenia. Am J Psychiatry 2019. 176:29–35 - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
